Dexamethasone Implants in Diabetic Macular Edema Patients with High Visual Acuity

Ophthalmic Research

Volumn 58, Issue 3, 2017, Pages 125-130

  Sacconi, Riccardo ^a,b   Parodi, Maurizio Battaglia ^b   Casati, Stefano ^a   Lattanzio, Rosangela ^b   Marchini, Giorgio ^a   Bandello, Francesco ^b  

^a UNIVERSITY OF VERONA   (Italy)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Dexamethasone; Diabetic retinopathy; High visual acuity; Macular edema; Optical coherence tomography; Ozurdex

Indexed keywords

DEXAMETHASONE; DRUG IMPLANT; GLUCOCORTICOID;

ADULT; AGED; ARTICLE; BEST CORRECTED VISUAL ACUITY; CASE STUDY; CENTRAL MACULAR THICKNESS; CLINICAL ARTICLE; CLINICAL TRIAL; DIABETIC MACULAR EDEMA; DRUG IMPLANT; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; INTERVENTION STUDY; INTRAOCULAR PRESSURE; MALE; OPTICAL COHERENCE TOMOGRAPHY DEVICE; PRIORITY JOURNAL; SIDE EFFECT; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; SUSTAINED DRUG RELEASE; COMPLICATION; DIABETIC RETINOPATHY; INTRAVITREAL DRUG ADMINISTRATION; MACULAR EDEMA; MIDDLE AGED; OPTICAL COHERENCE TOMOGRAPHY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; PROSPECTIVE STUDY; RETINA MACULA LUTEA; TIME FACTOR; TREATMENT OUTCOME; VERY ELDERLY; VISUAL ACUITY;

AGED; AGED, 80 AND OVER; DEXAMETHASONE; DIABETIC RETINOPATHY; DRUG IMPLANTS; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; INTRAVITREAL INJECTIONS; MACULA LUTEA; MACULAR EDEMA; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TIME FACTORS; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 85023754014     PISSN: 00303747     EISSN: 14230259     Source Type: Journal    
DOI: 10.1159/000477256     Document Type: Article

References (17)

1. Fong DS, Aiello LP, Ferris FL 3rd, Klein R: Diabetic retinopathy. Diabetes Care 2004; 27: 2540-2553.
2. Gillies MC, Lim LL, Campain A, et al: A randomized clinical trial of intravitreal bevacizumab versus intravitreal dexamethasone for diabetic macular edema: the BEVORDEX Study. Ophthalmology 2014; 121: 2473-2481.
3. Das A, McGuire PG, Rangasamy S: Diabetic macular edema: pathophysiology and novel therapeutic targets. Ophthalmology 2015; 122: 1375-1394.
4. Semeraro F, Cancarini A, dell'Omo R, et al: Diabetic retinopathy: vascular and inflammatory disease. J Diabetes Res 2015; 2015: 582060.
5. American Diabetes Association: Standards of medical care in diabetes - 2012. Diabetes Care 2012; 35(suppl 1):S11-S63.
6. Nguyen QD, Brown DM, Marcus DM, et al; RISE and RIDE Research Group: Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE. Ophthalmology 2012; 119: 789-801.
7. Brown DM, Nguyen QD, Marcus DM, et al; RIDE and RISE Research Group: Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDE. Ophthalmology 2013; 120: 2013-2022.
8. Edelman JL, Lutz D, Castro MR: Corticosteroids inhibit VEGF-induced vascular leakage in a rabbit model of blood-retinal and bloodaqueous barrier breakdown. Exp Eye Res 2005; 80: 249-258.
9. Boyer DS, Yoon YH, Belfort R Jr, et al; Ozurdex MEAD Study Group: Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema. Ophthalmology 2014; 121: 1904-1914.
10. Fraser-Bell S, Lim LL, Campain A, et al: Bevacizumab or dexamethasone implants for DME: 2-year results (the BEVORDEX Study). Ophthalmology 2016; 123: 1399-1401.
11. Dutra Medeiros M, Postorino M, Navarro R, et al: Dexamethasone intravitreal implant for treatment of patients with persistent diabetic macular edema. Ophthalmologica 2014; 231: 141-146.
12. Zhioua I, Semoun O, Lalloum F, Souied EH: Intravitreal dexamethasone implant in patients with ranibizumab persistent diabetic macular edema. Retina 2015; 35: 1429-1435.
13. Iacono P, Parodi MB, Scaramuzzi M, Bandello F: Morphological and functional changes in recalcitrant diabetic macular oedema after intravitreal dexamethasone implant. Br J Ophthalmol 2017; 101: 791-795.
14. Haller JA, Kuppermann BD, Blumenkranz MS, et al; Dexamethasone DDS Phase II Study Group: Randomized controlled trial of an intravitreous dexamethasone drug delivery system in patients with diabetic macular edema. Arch Ophthalmol 2010; 128: 289-296.
15. Gillies MC, Sutter FK, Simpson JM, et al: Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebo-controlled, randomized clinical trial. Ophthalmology 2006; 113: 1533-1538.
16. Scaramuzzi M, Querques G, Spina CL, et al: Repeated intravitreal dexamethasone implant (Ozurdex) for diabetic macular edema. Retina 2015; 35: 1216-1222.
17. Mastropasqua R, Toto L, Borrelli E, et al: Morphology and function over a one-year follow up period after intravitreal dexamethasone implant (Ozurdex) in patients with diabetic macular edema. PLoS One 2015; 10: e0145663.